文献
J-GLOBAL ID:202202211054792012
整理番号:22A0738337
クローン病におけるウステキヌマブ治療の5年間の有効性と安全性: IM-UNITI試験【JST・京大機械翻訳】
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial
著者 (14件):
Sandborn William J.
(Division of Gastroenterology, Clinical Operations, Department of Medicine, University of California San Diego Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, California)
,
Rebuck Rory
(Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania)
,
Wang Yuhua
(Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania)
,
Zou Bin
(Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania)
,
Adedokun Omoniyi J.
(Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania)
,
Gasink Christopher
(Medical Affairs, Janssen Scientific Affairs, LLC, Horsham, Pennsylvania)
,
Sands Bruce E.
(Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, New York)
,
Hanauer Stephen B.
(Digestive Health Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois)
,
Targan Stephan
(F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California)
,
Ghosh Subrata
(School of Medicine and Health, University College Cork, Ireland and Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom)
,
de Villiers Willem J.S.
(University of Stellenbosch, Stellenbosch, South Africa)
,
Colombel Jean-Frederic
(Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, New York)
,
Feagan Brian G.
(Robarts Clinical Trials, Robarts Research Institute, London, Canada)
,
Lynch John P.
(Immunology, Janssen Research & Development, LLC, Spring House, Pennsylvania)
資料名:
Clinical Gastroenterology and Hepatology
(Clinical Gastroenterology and Hepatology)
巻:
20
号:
3
ページ:
578-590.e4
発行年:
2022年
JST資料番号:
W3126A
ISSN:
1542-3565
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)